Close Menu
Home » Genetics & Genomics Business, Policy & Funding

Genetics & Genomics Business, Policy & Funding

Breaking news on Genetics & Genomics business, policy & funding.

Fusion Genomics Clinically Validating NGS Test for Infectious Disease; Eyes 2020 FDA Submission

Premium

The firm has opened a $10 million Series A financing round that it expects to close in late summer to support running clinical studies for its assay.

Novacyt Posts 4 Percent Drop in Preliminary 2019 Revenues

The company attributed the revenue decline in part to working capital restraints and long manufacturing lead times, which are being addressed currently.

Saga, Servier Sign Liquid Biopsy Services Deal

Saga has developed a digital PCR-based technology that it says can detect circulating tumor DNA with a mutational allele frequency of 0.001 percent.

Predictive Technology Group, Atrin Pharmaceuticals Launch Oncology MDx Collaboration

Atrin will use Predictive's GenDB databases and women's health biobank to study germline mutations in DNA damage and response inhibitor pathways. 

PerkinElmer Q4 Revenues Rise 7 Percent

CEO Prahlad Singh said the firm is developing a PCR- and antibody-based assay for the novel coronavirus 2019-nCoV and is working with the Chinese NMPA.

Jan 27, 2020

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

Jan 27, 2020

Meridian Stock Rises 21 Percent After Reagent Mix Used in Coronavirus Testing

Jan 27, 2020

Natera Sues ArcherDx for Infringement of New Target Amplification Patent

Jan 27, 2020

Noscendo, University Hospital Bonn Partner on Pathogen-Detection Platform Development

Jan 24, 2020

Predictive Oncology to Acquire Quantitative Medicine

Jan 24, 2020

Federal Court Whittles Down Fluidigm Lawsuit Against IonPath

Jan 24, 2020

British Columbia Team to Study Campylobacter Omics With $500K in Genome BC, Genome Canada Funding

Jan 24, 2020

NIH to Establish Expert Panels for Curation of Disease-Linked Genes, Variants

Jan 24, 2020

Adaptive Biotechnologies Prices Public Offering of Stock

Jan 24, 2020

New Products Posted to GenomeWeb: Qiagen, IDT, Meridian Bioscience, More

Jan 23, 2020

Immunis.AI Targets Late 2020 Prostate Cancer Risk Core Assay Launch

Premium
Jan 23, 2020

23andMe Lays off 100 Employees Across Consumer Business

Jan 23, 2020

Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing

Premium
Jan 23, 2020

RNAssist Licenses Biomolecule Stabilization Tech to QCMD

Jan 23, 2020

Startup BioSkryb Eyes Oncology Applications for Single-Cell DNA Sequencing

Premium
Jan 23, 2020

Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery

Jan 23, 2020

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Jan 22, 2020

M&A Deals in MDx/Omics Research Tools Space Up 13 Percent in 2019

Premium
Jan 22, 2020

10x Genomics Lawsuit Over Exclusivity of Harvard Single-Cell IP License Going to Trial

Jan 22, 2020

Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

More articles

The Scan

Harvard Prof Charged

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Level of Transparency

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

But What About That Preserved Frog Smell?

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

PNAS Papers Describe Amish De Novo Mutation Decrease, RNA Sequencing Method, Precision Med Results

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.